Atl1102 is doing a trial with non ambulant boys in DMD in...

Atl1102 is doing a trial with non ambulant boys in DMD in combination with steroids

Heres the interesting thing !
After the 12 month trial and Atl1102 is safe and tolerable and past 6 month futility showing signs of efficacy..

Then the

Physicians, could choose to use the drug in combination ahead of an approval (off-label as noted above) a decision that will be based on their view of the likely efficacy and safety of the combination.
Im talking about INFLAMMATION (Atl1102 )

So : Atl 1102 could be used to reduce inflammation ( Corticosteroods will get the flick imo)

Conclusion
In 12 months Atl1102 could be earning an income re anti inflammation in Europe and the US….imo